Nav leads the state and local work for McKinsey’s Public Sector Practice in North America and is a leader in the company’s Pharmaceutical & Medical Products and Strategy & Corporate Finance Practices, with a focus on innovation. Nav brings deep business expertise in strategy, innovation, operations, business development, and risk. Additionally, Nav spearheads McKinsey’s knowledge initiatives on R&D productivity in the pharmaceutical industry and leads its Center for Asset Optimization. He is the immediate past chair of the board of the Greater Boston Chamber of Commerce, a member of Governor Baker’s Task Force on the Future of Transportation, and hosts Imagine Get-Togethers that convene cross-sector leaders on cutting-edge topics, such as synthetic biology, commercial applications of drones, and the future of space exploration.
In Conversation with:
Shirley Leung, Columnist and Associate Editor, The Boston Globe
Shirley writes on everything from the intersection of business and politics to gender issues in the workplace. She is also a WGBH news contributor appearing on “Boston Public Radio” and “Greater Boston,” and a regular guest on New England Cable News. Her columns have earned her many fans – and trolls on Twitter. According to Boston Magazine in which she is named one of the 100 Most Influential People in Boston : “Love her or hate her, you had to read her.” Previously, Shirley was the Globe’s business editor, where she oversaw its award-winning coverage of the 2008 financial crisis. Prior to the Globe, she was a staff reporter at the Wall Street Journal.
David Lucchino, Co-Founder, President, and Chief Executive Officer, Frequency Therapeutics
David is an entrepreneur and business leader currently at the helm of Frequency Therapeutics, a clinical-stage, venture-backed company that is advancing a novel way to enlist the body’s native regenerative abilities to treat chronic conditions, including noise-induced hearing loss and diseases of the skin, muscles and gastrointestinal tract. David’s background includes having co-founded and led Semprus Biosciences, a medical device firm; serving as CEO of Entegra Bio; and Senior Executive at Polaris Partners. David is Chairman of the Board of Directors of MassBio, the voice of the biotechnology industry in Massachusetts. He started his life sciences career as a co-founder and managing director of LaunchCyte, a biomedical intellectual property acquisition and development firm.
Daniela Rus, Professor and Director of Computer Science and Artificial Intelligence (CSAIL), MIT
Daniela’s research interests focus on robotics, artificial intelligence, and data science, specifically developing the science and engineering of autonomy. The applications of her work include transportation, manufacturing, agriculture, construction, the environment, underwater exploration, smart cities, medicine, and in-home tasks. Daniela is the Director of the Toyota CSAIL Joint Research Center whose focus is the advancement of AI research and its applications to intelligent vehicles. She is a member of MIT’s task force on the Future of Work, the Toyota Research Institute advisory board, a Class of 2002 MacArthur Fellow, and the recipient of the 2017 Engelberger Robotics Award from the Robotics Industries Association.
Corey Thomas, Chief Executive Officer, Rapid7
As President, CEO, and member of the board, Corey Thomas leads Rapid7 (NASDAQ: RPD), named by the Boston Business Journal as the Commonwealth’s third largest cybersecurity company. Corey also serves on the board of the newly- formed Cyber Threat Alliance, the non-profit association of cybersecurity companies. His previous positions include VP of marketing at Parallels, Inc., a virtualization technology company; group project manager of the Microsoft Server and Tools division, launching the worldwide availability of SQL Server 2005; and steering product planning for Microsoft’s data platform; and a consultant at Deloitte Consulting. On the civic front, Corey is a member of the Board of Blue Cross Blue Shield of Massachusetts.
Thank you to our lead sponsor, TD Bank
Thank you to our partner sponsors, Bowditch & Dewey and WPI
For more information, contact Annie O’Connell, 617-924-4600, ext. 13
Like so many across the globe, due to Covid-19, MassEcon is not working from the office for the foreseeable future, but we’re still up and running. With much consideration, we will not be holding in-person meetings until at least mid-July, but will be holding committee meetings via conference call, strategizing on how to bring you programming and business opportunities, and building our membership. Feel free to reach out to any of our staff with questions, concerns, or ideas on how we can continue to work together through this time. We wish you the best during this difficult time.
